Topiramate in pregnancy
Preliminary experience from the UK Epilepsy and Pregnancy Register
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objectives: Topiramate (Topamax®) is licensed to be used, either in monotherapy or as adjunctive treatment, for generalized tonic clonic seizures or partial seizures with or without secondary generalization and for prevention of migraine. The safety of topiramate in human pregnancy is largely unknown. Here we report on our experience of pregnancies exposed to topiramate.
Methods: This study is part of a prospective, observational, registration and follow-up study. Suitable cases are women with epilepsy who become pregnant while taking topiramate either singly or along with other antiepileptic drugs (AEDs), and who are referred before outcome of the pregnancy is known. The main outcome measure is the major congenital malformation (MCM) rate. Secondary outcomes include risk of specific MCM, minor malformation rate, birthweight, and gestational age at delivery.
Results: Full outcome data are available on 203 pregnancies. Of these, 178 resulted in live birth; 16 had an MCM (9.0%; 95% CI 5.6% to 14.1%). Three MCMs were observed in 70 monotherapy exposures (4.8%; 95% CI 1.7% to 13.3%) and 13 in cases exposed to topiramate as part of a polytherapy regimen (11.2%; 95% CI 6.7% to 18.2%). Four of the MCMs were oral clefts (2.2%; 95% CI 0.9% to 5.6%). Four cases of hypospadias were reported (5.1%; 95% CI 0.2% to 10.1%) among 78 known live male births of which two were classified as major malformations.
Conclusions: The number of outcomes of human pregnancies exposed to topiramate is low, but the major congenital malformation rate for topiramate polytherapy raises some concerns. Overall, the rate of oral clefts observed was 11 times the background rate. Although the present data provide new information, they should be interpreted with caution due to the sample size and wide confidence intervals.
Glossary
- AED=
- antiepileptic drug;
- MCM=
- major congenital malformation;
- SGA=
- small for gestational age.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
- Topiramate in pregnancy: Preliminary experience from the UK Epilepsy and Pregnancy Register
- María-Luisa Martínez-Frías, Professor of the Faculty of Medicine, Director of the Research Center of Congenital Anomalies (CIAC), Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Madrid, Spainmlmartinez.frias@isciii.es
Submitted November 07, 2008 - Reply from the authors
- John Craig, MRCP, Royal Group of Hospitals, Belfast,, Grosvenor Road, Belfast, BT12 6BA, UKjohn.craig@belfasttrust.hscni.net
- S. Hunt, MRCP, A. Russell, MRCP (Glasgow), J. Morrow, MD
Submitted November 07, 2008
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
Levetiracetam in pregnancyResults from the UK and Ireland epilepsy and pregnancy registersEllen Mawhinney, John Craig, Jim Morrow et al.Neurology, January 09, 2013 -
Article
Lamotrigine use in pregnancy and risk of orofacial cleft and other congenital anomaliesHelen Dolk, Hao Wang, Maria Loane et al.Neurology, April 06, 2016 -
Articles
Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancyL. B. Holmes, E. J. Baldwin, C. R. Smith et al.Neurology, April 30, 2008 -
Views and Reviews
Pregnancy registries in epilepsyA consensus statement on health outcomesK. J. Meador, P. B. Pennell, C. L. Harden et al.Neurology, August 13, 2008